- Friday 1st of October 2021
gene therapy-based I-O drug development
With professional service and various advanced equipment at Creative Biolabs, GTOnco™ platform provides high-quality preclinical profiling and monitoring of immune responses for gene therapy-based I-O drug development. Utilizing the most effective combination of assays available to identify promising I-O therapeutics, our broad range of well-established assays and animal models allow clients to choose the most appropriate study design and screening method to identify the best option and optimize lead candidates.
Latest News
- Friday 1st of October 2021
“BIZ 2021” Entrepreneurial Day competition
- Friday 1st of October 2021
Workshop on modern assessment and the Use of Zoom Software in Learner-Centered Classroom (Academic staff)
- Friday 19th of March 2021
“Let’s Plant Trees for a Better Environment 2021”
- Friday 19th of March 2021
Biz 2020 – UWU Entrepreneurs’ Day
- Friday 19th of March 2021
Faculty of Management signs MoU with the Sri Lanka Institute of Marketing
- Friday 19th of March 2021
0 Replies:
Leave a Reply